{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:32:58Z","timestamp":1790548378571,"version":"4.1.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10072-024-07802-3","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T04:01:38Z","timestamp":1728619298000},"page":"593-604","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Mechanistic insights on the role of Nrf-2 signalling in Huntington\u2019s disease"],"prefix":"10.1007","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6061-2012","authenticated-orcid":false,"given":"Veerta","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3656-669X","authenticated-orcid":false,"given":"Prateek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,11]]},"reference":[{"key":"7802_CR1","doi-asserted-by":"publisher","first-page":"110373","DOI":"10.1016\/j.biopha.2020.110373","volume":"129","author":"V Sharma","year":"2020","unstructured":"Sharma V, Kaur A, Singh TG (2020) Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer\u2019s disease. Biomed Pharmacother 129:110373","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"7802_CR2","doi-asserted-by":"publisher","first-page":"236","DOI":"10.3390\/antiox12020236","volume":"12","author":"WJ He","year":"2023","unstructured":"He WJ, Lv CH, Chen Z, Shi M, Zeng CX, Hou DX, Qin S (2023) The regulatory effect of phytochemicals on chronic diseases by targeting Nrf2-ARE signaling pathway. Antioxidants 12(2):236","journal-title":"Antioxidants"},{"key":"7802_CR3","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.pharmthera.2015.11.003","volume":"157","author":"I Buendia","year":"2016","unstructured":"Buendia I, Michalska P, Navarro E, Gameiro I, Egea J, Leon R (2016) Nrf2\u2013ARE pathway: an emerging target against oxidative stress and neuroinflammation in neurodegenerative diseases. Pharmacol Ther 157:84\u2013104","journal-title":"Pharmacol Ther"},{"issue":"3","key":"7802_CR4","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/biof.1013","volume":"38","author":"MA SorollaBardaj\u00ed","year":"2012","unstructured":"SorollaBardaj\u00ed MA, Rodr\u00edguez Colman MJ, Espinosa VL, TamaritSumalla J, Ros Salvador J, CabiscolCatal\u0101 E (2012) Protein oxidation in Huntington disease. BioFactors 38(3):173\u2013185","journal-title":"BioFactors"},{"key":"7802_CR5","doi-asserted-by":"crossref","unstructured":"Ellrichmann G, Petrasch-Parwez E, Lee DH, Reick C, Arning L, Saft C, ... Linker RA (2011) Efficacy of fumaric acid esters in the R6\/2 and YAC128 models of Huntington's disease. PloS One 6(1):e16172","DOI":"10.1371\/journal.pone.0016172"},{"issue":"2","key":"7802_CR6","first-page":"129","volume":"5","author":"O Eje","year":"2023","unstructured":"Eje O, Ogbonna CV, Onoyima CS, Nduka FO (2023) Huntington Disease: mechanism of Pathogenesis and recent developments in its therapeutic strategies: a review. J Chem Rev 5(2):129\u2013142","journal-title":"J Chem Rev"},{"key":"7802_CR7","doi-asserted-by":"crossref","unstructured":"Parsons MP, Raymond LA (2023) Huntington disease. In\u00a0Neurobiology of brain disorders. Academic Press, pp 275\u2013292","DOI":"10.1016\/B978-0-323-85654-6.00042-3"},{"issue":"1","key":"7802_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/ene.13413","volume":"25","author":"P McColgan","year":"2018","unstructured":"McColgan P, Tabrizi SJ (2018) Huntington\u2019s disease: a clinical review. Eur J Neurol 25(1):24\u201334","journal-title":"Eur J Neurol"},{"key":"7802_CR9","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/978-3-642-45106-5_14","volume":"220","author":"C Zuccato","year":"2014","unstructured":"Zuccato C, Cattaneo E (2014) Huntington\u2019s disease. Handb Exp Pharmacol 220:357\u2013409. https:\/\/doi.org\/10.1007\/978-3-642-45106-5_14","journal-title":"Handb Exp Pharmacol"},{"issue":"10","key":"7802_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/s41582-020-0389-4","volume":"16","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi SJ, Flower MD, Ross CA, Wild EJ (2020) Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol 16(10):529\u2013546","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"7802_CR11","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1128\/MCB.01434-12","volume":"33","author":"JT Lin","year":"2013","unstructured":"Lin JT, Chang WC, Chen HM, Lai HL, Chen CY, Tao MH, Chern Y (2013) Regulation of feedback between protein kinase A and the proteasome system worsens Huntington\u2019s disease. Mol Cell Biol 33(5):1073\u20131084","journal-title":"Mol Cell Biol"},{"issue":"7","key":"7802_CR12","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.drudis.2014.02.014","volume":"19","author":"CJ Cortes","year":"2014","unstructured":"Cortes CJ, La Spada AR (2014) The many faces of autophagy dysfunction in Huntington\u2019s disease: from mechanism to therapy. Drug Discov Today 19(7):963\u2013971","journal-title":"Drug Discov Today"},{"key":"7802_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2013.02.008","volume":"66","author":"SK Niture","year":"2014","unstructured":"Niture SK, Khatri R, Jaiswal AK (2014) Regulation of Nrf2\u2014an update. Free Radical Biol Med 66:36\u201344","journal-title":"Free Radical Biol Med"},{"issue":"5","key":"7802_CR14","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1128\/MCB.01191-13","volume":"34","author":"T Fukutomi","year":"2014","unstructured":"Fukutomi T, Takagi K, Mizushima T, Ohuchi N, Yamamoto M (2014) Kinetic, thermodynamic, and structural characterizations of the association between Nrf2-DLGex degron and Keap1. Mol Cell Biol 34(5):832\u2013846","journal-title":"Mol Cell Biol"},{"key":"7802_CR15","doi-asserted-by":"crossref","unstructured":"Wang H, Liu K, Geng M, Gao P, Wu X, Hai Y, ... Tang X (2013) RXR\u03b1 inhibits the NRF2-ARE signaling pathway through a direct interaction with the Neh7 domain of NRF2. Cancer Res 73(10):3097\u20133108","DOI":"10.1158\/0008-5472.CAN-12-3386"},{"key":"7802_CR16","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.neuropharm.2013.11.004","volume":"79","author":"M Sandberg","year":"2014","unstructured":"Sandberg M, Patil J, D\u2019Angelo B, Weber SG, Mallard C (2014) NRF2-regulation in brain health and disease: implication of cerebral inflammation. Neuropharmacology 79:298\u2013306","journal-title":"Neuropharmacology"},{"issue":"14","key":"7802_CR17","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.3390\/ijms20143433","volume":"20","author":"F Sivandzade","year":"2019","unstructured":"Sivandzade F, Bhalerao A, Cucullo L (2019) Cerebrovascular and neurological disorders: protective role of NRF2. Int J Mol Sci 20(14):3433","journal-title":"Int J Mol Sci"},{"issue":"6","key":"7802_CR18","doi-asserted-by":"publisher","first-page":"376","DOI":"10.4110\/in.2011.11.6.376","volume":"11","author":"HJ Kim","year":"2011","unstructured":"Kim HJ, Zheng M, Kim SK, Cho JJ, Shin CH, Joe Y, Chung HT (2011) CO\/HO-1 induces NQO-1 expression via Nrf2 activation. Immune Network 11(6):376","journal-title":"Immune Network"},{"issue":"3","key":"7802_CR19","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/ma15030804","volume":"15","author":"T Bhattacharya","year":"2022","unstructured":"Bhattacharya T, Soares GABE, Chopra H, Rahman MM, Hasan Z, Swain SS, Cavalu S (2022) Applications of phyto-nanotechnology for the treatment of neurodegenerative disorders. Materials 15(3):804","journal-title":"Materials"},{"key":"7802_CR20","doi-asserted-by":"crossref","unstructured":"Zhang J, Zhou R, Xiang C, Fan F, Gao J, Zhang Y, ... Yang H (2020) Enhanced thioredoxin, glutathione and Nrf2 antioxidant systems by safflower extract and aceglutamide attenuate cerebral ischaemia\/reperfusion injury. J Cell Mol Med 24(9):4967\u20134980","DOI":"10.1111\/jcmm.15099"},{"issue":"3","key":"7802_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/jnc.15969","volume":"167","author":"R Liu","year":"2023","unstructured":"Liu R, Yang J, Li Y, Xie J, Wang J (2023) Heme oxygenase-1: The roles of both good and evil in neurodegenerative diseases. J Neurochem 167(3):347\u2013361","journal-title":"J Neurochem"},{"issue":"17","key":"7802_CR22","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1089\/ars.2020.8065","volume":"32","author":"MM Facchinetti","year":"2020","unstructured":"Facchinetti MM (2020) Heme-oxygenase-1. Antioxid Redox Signal 32(17):1239\u20131242","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"7802_CR23","first-page":"123","volume":"4","author":"OE Ifeanyi","year":"2018","unstructured":"Ifeanyi OE (2018) A review on free radicals and antioxidants. Int J Curr Res Med Sci 4(2):123\u2013133","journal-title":"Int J Curr Res Med Sci"},{"key":"7802_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.vph.2015.03.005","volume":"71","author":"HN Siti","year":"2015","unstructured":"Siti HN, Kamisah Y, Kamsiah JJVP (2015) The role of oxidative stress, antioxidants and vascular inflammation in cardiovascular disease (a review). Vascul Pharmacol 71:40\u201356","journal-title":"Vascul Pharmacol"},{"issue":"1","key":"7802_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1021\/acs.jmedchem.0c01704","volume":"64","author":"P Wang","year":"2020","unstructured":"Wang P, Gong Q, Hu J, Li X, Zhang X (2020) Reactive oxygen species (ROS)-responsive prodrugs, probes, and theranostic prodrugs: applications in the ROS-related diseases. J Med Chem 64(1):298\u2013325","journal-title":"J Med Chem"},{"key":"7802_CR26","doi-asserted-by":"publisher","first-page":"111729","DOI":"10.1016\/j.biopha.2021.111729","volume":"140","author":"AK Grewal","year":"2021","unstructured":"Grewal AK, Singh TG, Sharma D, Sharma V, Singh M, Rahman MH, Abdel-Daim MM (2021) Mechanistic insights and perspectives involved in neuroprotective action of quercetin. Biomed Pharmacother 140:111729","journal-title":"Biomed Pharmacother"},{"key":"7802_CR27","doi-asserted-by":"crossref","unstructured":"Yablonska S, Ganesan V, Ferrando LM, Kim J, Pyzel A, Baranova OV, ... Friedlander RM (2019) Mutant huntingtin disrupts mitochondrial proteostasis by interacting with TIM23. Proc Natl Acad Sci 116(33):16593\u201316602","DOI":"10.1073\/pnas.1904101116"},{"issue":"6","key":"7802_CR28","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1074\/jbc.RA117.001440","volume":"294","author":"S Son","year":"2019","unstructured":"Son S, Bowie LE, Maiuri T, Hung CL, Desmond CR, Xia J, Truant R (2019) High-mobility group box 1 links sensing of reactive oxygen species by huntingtin to its nuclear entry. J Biol Chem 294(6):1915\u20131923","journal-title":"J Biol Chem"},{"issue":"3","key":"7802_CR29","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.scr.2013.08.010","volume":"11","author":"I Jonson","year":"2013","unstructured":"Jonson I, Ougland R, Klungland A, Larsen E (2013) Oxidative stress causes DNA triplet expansion in Huntington\u2019s disease mouse embryonic stem cells. Stem Cell Res 11(3):1264\u20131271","journal-title":"Stem Cell Res"},{"issue":"17","key":"7802_CR30","doi-asserted-by":"publisher","first-page":"9592","DOI":"10.3390\/ijms22179592","volume":"22","author":"E Zgorzynska","year":"2021","unstructured":"Zgorzynska E, Dziedzic B, Walczewska A (2021) An overview of the Nrf2\/ARE pathway and its role in neurodegenerative diseases. Int J Mol Sci 22(17):9592","journal-title":"Int J Mol Sci"},{"issue":"23","key":"7802_CR31","doi-asserted-by":"publisher","first-page":"15272","DOI":"10.3390\/ijms232315272","volume":"23","author":"P Tucci","year":"2022","unstructured":"Tucci P, Lattanzi R, Severini C, Saso L (2022) Nrf2 pathway in huntington\u2019s disease (hd): What is its role? Int J Mol Sci 23(23):15272","journal-title":"Int J Mol Sci"},{"key":"7802_CR32","doi-asserted-by":"crossref","unstructured":"Faideau M, Kim J, Cormier K, Gilmore R, Welch M, Auregan G, ... Bonvento G (2010) In vivo expression of polyglutamine-expanded huntingtin by mouse striatal astrocytes impairs glutamate transport: a correlation with Huntington's disease subjects. Hum Mol Gen 19(15):3053\u20133067","DOI":"10.1093\/hmg\/ddq212"},{"issue":"9","key":"7802_CR33","doi-asserted-by":"publisher","first-page":"e0163479","DOI":"10.1371\/journal.pone.0163479","volume":"11","author":"FB Rodrigues","year":"2016","unstructured":"Rodrigues FB, Byrne LM, McColgan P, Robertson N, Tabrizi SJ, Zetterberg H, Wild EJ (2016) Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington\u2019s disease. PLoS ONE 11(9):e0163479","journal-title":"PLoS ONE"},{"key":"7802_CR34","doi-asserted-by":"publisher","first-page":"787258","DOI":"10.3389\/fncel.2021.787258","volume":"15","author":"S Saha","year":"2022","unstructured":"Saha S, Buttari B, Profumo E, Tucci P, Saso L (2022) A perspective on Nrf2 signaling pathway for neuroinflammation: a potential therapeutic target in Alzheimer\u2019s and Parkinson\u2019s diseases. Front Cell Neurosci 15:787258","journal-title":"Front Cell Neurosci"},{"issue":"11","key":"7802_CR35","doi-asserted-by":"publisher","first-page":"9666","DOI":"10.3390\/ijms24119666","volume":"24","author":"JI Park","year":"2023","unstructured":"Park JI (2023) MAPK-ERK Pathway. Int J Mol Sci 24(11):9666","journal-title":"Int J Mol Sci"},{"key":"7802_CR36","doi-asserted-by":"crossref","unstructured":"Behl T, Kaur G, Sehgal A, Bhardwaj S, Singh S, Buhas C, ... Bungau S (2021) Multifaceted role of matrix metalloproteinases in neurodegenerative diseases: Pathophysiological and therapeutic perspectives. Int J Mol Sci 22(3):1413","DOI":"10.3390\/ijms22031413"},{"key":"7802_CR37","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1007\/s12035-015-9230-2","volume":"53","author":"M Jang","year":"2016","unstructured":"Jang M, Cho IH (2016) Sulforaphane ameliorates 3-nitropropionic acid-induced striatal toxicity by activating the Keap1-Nrf2-ARE pathway and inhibiting the MAPKs and NF-\u03baB pathways. Mol Neurobiol 53:2619\u20132635","journal-title":"Mol Neurobiol"},{"issue":"8","key":"7802_CR38","doi-asserted-by":"publisher","first-page":"6975","DOI":"10.1007\/s11033-023-08573-4","volume":"50","author":"V Sharma","year":"2023","unstructured":"Sharma V, Singh TG (2023) Drug induced nephrotoxicity-A mechanistic approach. Mol Biol Rep 50(8):6975\u20136986","journal-title":"Mol Biol Rep"},{"key":"7802_CR39","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bbi.2019.03.001","volume":"80","author":"M Jang","year":"2019","unstructured":"Jang M, Choi JH, Chang Y, Lee SJ, Nah SY, Cho IH (2019) Gintonin, a ginseng-derived ingredient, as a novel therapeutic strategy for Huntington\u2019s disease: Activation of the Nrf2 pathway through lysophosphatidic acid receptors. Brain Behav Immun 80:146\u2013162","journal-title":"Brain Behav Immun"},{"key":"7802_CR40","doi-asserted-by":"crossref","unstructured":"Kim EJ, Jang M, Lee MJ, Choi JH, Lee SJ, Kim SK, ... Cho IH (2017) Schisandra chinensis stem ameliorates 3-nitropropionic acid-induced striatal toxicity via activation of the Nrf2 pathway and inhibition of the MAPKs and NF-\u03baB pathways. Front Pharmacol 8:673","DOI":"10.3389\/fphar.2017.00673"},{"key":"7802_CR41","doi-asserted-by":"publisher","first-page":"100190","DOI":"10.1016\/j.prmcm.2022.100190","volume":"5","author":"S Singh","year":"2022","unstructured":"Singh S, Arthur R, Upadhayay S, Kumar P (2022) Ferulic acid ameliorates neurodegeneration via the Nrf2\/ARE signalling pathway: A Review. Pharmacol Res - Mod Chin Med 5:100190","journal-title":"Pharmacol Res - Mod Chin Med"},{"issue":"8","key":"7802_CR42","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s11064-022-03620-1","volume":"47","author":"V Sharma","year":"2022","unstructured":"Sharma V, Singh TG, Mannan A (2022) Therapeutic implications of glucose transporters (GLUT) in cerebral ischemia. Neurochem Res 47(8):2173\u20132186","journal-title":"Neurochem Res"},{"key":"7802_CR43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.neuroscience.2012.07.060","volume":"227","author":"K Gopinath","year":"2012","unstructured":"Gopinath K, Sudhandiran G (2012) Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway. Neuroscience 227:134\u2013143","journal-title":"Neuroscience"},{"key":"7802_CR44","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s11010-015-2525-9","volume":"409","author":"G Kulasekaran","year":"2015","unstructured":"Kulasekaran G, Ganapasam S (2015) Neuroprotective efficacy of naringin on 3-nitropropionic acid-induced mitochondrial dysfunction through the modulation of Nrf2 signaling pathway in PC12 cells. Mol Cell Biochem 409:199\u2013211","journal-title":"Mol Cell Biochem"},{"key":"7802_CR45","doi-asserted-by":"publisher","first-page":"740966","DOI":"10.3389\/fphar.2021.740966","volume":"12","author":"AM Mustafa","year":"2021","unstructured":"Mustafa AM, Rabie MA, Zaki HF, Shaheen AM (2021) Inhibition of Brain GTP cyclohydrolase I attenuates 3-nitropropionic acid-induced striatal toxicity: involvement of Mas receptor\/PI3k\/Akt\/CREB\/BDNF axis. Front Pharmacol 12:740966","journal-title":"Front Pharmacol"},{"issue":"1","key":"7802_CR46","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1007\/s13311-019-00805-5","volume":"17","author":"NH Sayed","year":"2020","unstructured":"Sayed NH, Fathy N, Kortam MA, Rabie MA, Mohamed AF, Kamel AS (2020) Vildagliptin attenuates Huntington\u2019s disease through activation of GLP-1 receptor\/PI3K\/Akt\/BDNF pathway in 3-nitropropionic acid rat model. Neurotherapeutics 17(1):252\u2013268","journal-title":"Neurotherapeutics"},{"key":"7802_CR47","doi-asserted-by":"crossref","unstructured":"Antar SA, Abdo W, Taha RS, Farage AE, El-Moselhy LE, Amer ME, ... Mahmoud AM (2022) Telmisartan attenuates diabetic nephropathy by mitigating oxidative stress and inflammation, and upregulating Nrf2\/HO-1 signaling in diabetic rats. Life Sci 291:120260","DOI":"10.1016\/j.lfs.2021.120260"},{"key":"7802_CR48","doi-asserted-by":"publisher","first-page":"120480","DOI":"10.1016\/j.lfs.2022.120480","volume":"297","author":"NOA Rasheed","year":"2022","unstructured":"Rasheed NOA, Ibrahim WW (2022) Telmisartan neuroprotective effects in 3-nitropropionic acid Huntington\u2019s disease model in rats: Cross talk between PPAR-\u03b3 and PI3K\/Akt\/GSK-3\u03b2 pathway. Life Sci 297:120480","journal-title":"Life Sci"},{"key":"7802_CR49","doi-asserted-by":"publisher","first-page":"110957","DOI":"10.1016\/j.cbi.2024.110957","volume":"393","author":"MA Rabie","year":"2024","unstructured":"Rabie MA, Ghoneim AT, Fahmy MI, El-Yamany MF, Sayed RH (2024) Activation of alpha-7 nicotinic acetylcholine receptor by tropisetron mitigates 3-nitropropionic acid-induced Huntington\u2019s disease in rats: Role of PI3K\/Akt and JAK2\/NF-\u03baB signaling pathways. Chem Biol Interact 393:110957","journal-title":"Chem Biol Interact"},{"issue":"19","key":"7802_CR50","doi-asserted-by":"publisher","first-page":"2894","DOI":"10.1111\/bph.13569","volume":"173","author":"DS Lee","year":"2016","unstructured":"Lee DS, Jeong GS (2016) Butein provides neuroprotective and anti-neuroinflammatory effects through Nrf2\/ARE-dependent haem oxygenase 1 expression by activating the PI3K\/Akt pathway. Br J Pharmacol 173(19):2894\u20132909","journal-title":"Br J Pharmacol"},{"key":"7802_CR51","first-page":"5521519","volume":"1","author":"Y Liu","year":"2021","unstructured":"Liu Y, Zhang B, Liu J, Qiao C, Xue N, Lv H (2021) Li S (2021) Mogroside V alleviates lipopolysaccharide-induced neuroinflammation via inhibition of TLR4-MyD88 and activation of AKT\/AMPK-Nrf2 signaling pathway. Evid-Based Complementary Altern Med 1:5521519","journal-title":"Evid-Based Complementary Altern Med"},{"key":"7802_CR52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10495-020-01645-x","volume":"26","author":"S Ahmed","year":"2021","unstructured":"Ahmed S, Kwatra M, Gawali B, Panda SR, Naidu VGM (2021) Potential role of TrkB agonist in neuronal survival by promoting CREB\/BDNF and PI3K\/Akt signaling in vitro and in vivo model of 3-nitropropionic acid (3-NP)-induced neuronal death. Apoptosis 26:52\u201370","journal-title":"Apoptosis"},{"key":"7802_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1479-7364-5-5-485","volume":"5","author":"A Vassilopoulos","year":"2011","unstructured":"Vassilopoulos A, Fritz KS, Petersen DR, Gius D (2011) The human sirtuin family: evolutionary divergences and functions. Hum Genomics 5:1\u201312","journal-title":"Hum Genomics"},{"issue":"10","key":"7802_CR54","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.bbadis.2015.07.003","volume":"1852","author":"L Naia","year":"2015","unstructured":"Naia L, Rego AC (2015) Sirtuins: double players in Huntington\u2019s disease. Biochim Biophys Acta 1852(10):2183\u20132194","journal-title":"Biochim Biophys Acta"},{"key":"7802_CR55","doi-asserted-by":"crossref","unstructured":"Siegel D, Dehn DD, Bokatzian SS, Quinn K, Backos DS, Di Francesco A, ... Ross D (2018) Redox modulation of NQO1. PLoS One 13(1):e0190717","DOI":"10.1371\/journal.pone.0190717"},{"key":"7802_CR56","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11033-018-4172-1","volume":"45","author":"H Mahmoudinasab","year":"2018","unstructured":"Mahmoudinasab H, Saadat M (2018) Expressions of some antioxidant genes in SH-SY5Y cells treated with \u03b2-lapachone, morphine and electromagnetic field. Mol Biol Rep 45:379\u2013387","journal-title":"Mol Biol Rep"},{"key":"7802_CR57","doi-asserted-by":"crossref","unstructured":"Jiang M, Zheng J, Peng Q, Hou Z, Zhang J, Mori S, ... Duan W (2014) Sirtuin 1 activator SRT 2104 protects Huntington's disease mice.\u00a0Ann Clin Transl Neurol 1(12):1047\u20131052","DOI":"10.1002\/acn3.135"},{"issue":"2","key":"7802_CR58","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/1028415X.2019.1596613","volume":"24","author":"W Ruankham","year":"2021","unstructured":"Ruankham W, Suwanjang W, Wongchitrat P, Prachayasittikul V, Prachayasittikul S, Phopin K (2021) Sesamin and sesamol attenuate H2O2-induced oxidative stress on human neuronal cells via the SIRT1-SIRT3-FOXO3a signaling pathway. Nutr Neurosci 24(2):90\u2013101","journal-title":"Nutr Neurosci"},{"issue":"1","key":"7802_CR59","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/cns.12189","volume":"20","author":"J Chakraborty","year":"2014","unstructured":"Chakraborty J, Singh R, Dutta D, Naskar A, Rajamma U, Mohanakumar KP (2014) Quercetin improves behavioral deficiencies, restores astrocytes and microglia, and reduces serotonin metabolism in 3-nitropropionic acid-induced rat model of Huntington\u2019s disease. CNS Neurosci Ther 20(1):10\u201319","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"7802_CR60","doi-asserted-by":"publisher","first-page":"186","DOI":"10.5455\/jice.20140903012921","volume":"3","author":"D Jain","year":"2014","unstructured":"Jain D, Gangshettiwar A (2014) Combination of lycopene, quercetin and poloxamer 188 alleviates anxiety and depression in 3-nitropropionic acid-induced Huntington\u2019s disease in rats. J Intercult Ethnopharmacol 3(4):186","journal-title":"J Intercult Ethnopharmacol"},{"key":"7802_CR61","doi-asserted-by":"publisher","first-page":"551744","DOI":"10.3389\/fphar.2020.01225","volume":"11","author":"C Iside","year":"2020","unstructured":"Iside C, Scafuro M, Nebbioso A, Altucci L (2020) SIRT1 activation by natural phytochemicals: an overview. Front Pharmacol 11:551744","journal-title":"Front Pharmacol"},{"issue":"10","key":"7802_CR62","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3390\/antiox7100129","volume":"7","author":"T Corsello","year":"2018","unstructured":"Corsello T, Komaravelli N, Casola A (2018) Role of hydrogen sulfide in NRF2-and sirtuin-dependent maintenance of cellular redox balance. Antioxidants 7(10):129","journal-title":"Antioxidants"},{"key":"7802_CR63","doi-asserted-by":"crossref","unstructured":"Kim EN, Lim JH, Kim MY, Ban TH, Jang IA, Yoon HE, ... Choi BS (2018) Resveratrol, an Nrf2 activator, ameliorates aging-related progressive renal injury.\u00a0Aging 10(1):83","DOI":"10.18632\/aging.101361"},{"issue":"6","key":"7802_CR64","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1002\/med.21965","volume":"43","author":"SK Beura","year":"2023","unstructured":"Beura SK, Dhapola R, Panigrahi AR, Yadav P, Kumar R, Reddy DH, Singh SK (2023) Antiplatelet drugs: potential therapeutic options for the management of neurodegenerative diseases. Med Res Rev 43(6):1835\u20131877","journal-title":"Med Res Rev"},{"issue":"5","key":"7802_CR65","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1007\/s10787-022-01004-z","volume":"30","author":"WW Ibrahim","year":"2022","unstructured":"Ibrahim WW, Abdel Rasheed NO (2022) Diapocynin neuroprotective effects in 3-nitropropionic acid Huntington\u2019s disease model in rats: emphasis on Sirt1\/Nrf2 signaling pathway. Inflammopharmacology 30(5):1745\u20131758","journal-title":"Inflammopharmacology"},{"issue":"6","key":"7802_CR66","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.molcel.2017.05.032","volume":"66","author":"D Garcia","year":"2017","unstructured":"Garcia D, Shaw RJ (2017) AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol Cell 66(6):789\u2013800","journal-title":"Mol Cell"},{"issue":"1","key":"7802_CR67","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14737175.2021.1847645","volume":"21","author":"S Demar\u00e9","year":"2021","unstructured":"Demar\u00e9 S, Kothari A, Calcutt NA, Fernyhough P (2021) Metformin as a potential therapeutic for neurological disease: mobilizing AMPK to repair the nervous system. Expert Rev Neurother 21(1):45\u201363","journal-title":"Expert Rev Neurother"},{"key":"7802_CR68","doi-asserted-by":"crossref","unstructured":"Habib MZ, Tadros MG, Abd-Alkhalek HA, Mohamad MI, Eid DM, Hassan FE, ... Aboul-Fotouh S (2022) Harmine prevents 3-nitropropionic acid-induced neurotoxicity in rats via enhancing NRF2-mediated signaling: Involvement of p21 and AMPK. Eur J Pharmacol 927:175046","DOI":"10.1016\/j.ejphar.2022.175046"},{"issue":"3","key":"7802_CR69","first-page":"1683","volume":"41","author":"SY Park","year":"2018","unstructured":"Park SY, Choi MH, Park G, Choi YW (2018) Petasites japonicus bakkenolide B inhibits lipopolysaccharide-induced pro-inflammatory cytokines via AMPK\/Nrf2 induction in microglia. Int J Mol Med 41(3):1683\u20131692","journal-title":"Int J Mol Med"},{"key":"7802_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s12017-013-8261-y","volume":"16","author":"R Sandhir","year":"2014","unstructured":"Sandhir R, Yadav A, Mehrotra A, Sunkaria A, Singh A, Sharma S (2014) Curcumin nanoparticles attenuate neurochemical and neurobehavioral deficits in experimental model of Huntington\u2019s disease. NeuroMol Med 16:106\u2013118","journal-title":"NeuroMol Med"},{"issue":"2","key":"7802_CR71","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3233\/JHD-140106","volume":"3","author":"KR Bowles","year":"2014","unstructured":"Bowles KR, Jones L (2014) Kinase signalling in Huntington\u2019s disease. J Huntington\u2019s Dis 3(2):89\u2013123","journal-title":"J Huntington's Dis"},{"issue":"2","key":"7802_CR72","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1093\/hmg\/ddq460","volume":"20","author":"P Maher","year":"2011","unstructured":"Maher P, Dargusch R, Bodai L, Gerard PE, Purcell JM, Marsh JL (2011) ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington\u2019s disease. Hum Mol Genet 20(2):261\u2013270","journal-title":"Hum Mol Genet"},{"key":"7802_CR73","doi-asserted-by":"crossref","unstructured":"Yusuf IO, Chen HM, Cheng PH, Chang CY, Tsai SJ, Chuang JI, ... Yang SH (2019) Fibroblast growth factor 9 activates anti-oxidative functions of Nrf2 through ERK signalling in striatal cell models of Huntington's disease. Free Radical Biol Med 130:256\u2013266","DOI":"10.1016\/j.freeradbiomed.2018.10.455"},{"key":"7802_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2015.10.004","volume":"91","author":"AM Oliveira","year":"2015","unstructured":"Oliveira AM, Cardoso SM, Ribeiro M, Seixas RS, Silva AM, Rego AC (2015) Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington\u2019s disease mouse striatal cells. Neurochem Int 91:1\u201312","journal-title":"Neurochem Int"},{"issue":"9","key":"7802_CR75","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3390\/antiox8090388","volume":"8","author":"RA Santana-Mart\u00ednez","year":"2019","unstructured":"Santana-Mart\u00ednez RA, Silva-Islas CA, Fern\u00e1ndez-Orihuela YY, Barrera-Oviedo D, Pedraza-Chaverri J, Hern\u00e1ndez-Pando R, Maldonado PD (2019) The therapeutic effect of curcumin in quinolinic acid-induced neurotoxicity in rats is associated with BDNF, ERK1\/2, Nrf2, and antioxidant enzymes. Antioxidants 8(9):388","journal-title":"Antioxidants"},{"issue":"2","key":"7802_CR76","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.neuron.2014.12.019","volume":"85","author":"JH Lee","year":"2015","unstructured":"Lee JH, Tecedor L, Chen YH, Monteys AM, Sowada MJ, Thompson LM, Davidson BL (2015) Reinstating aberrant mTORC1 activity in Huntington\u2019s disease mice improves disease phenotypes. Neuron 85(2):303\u2013315","journal-title":"Neuron"},{"key":"7802_CR77","doi-asserted-by":"crossref","unstructured":"Chopra V, Quinti L, Kim J, Vollor L, Narayanan KL, Edgerly C, ... Kazantsev AG (2012) The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington\u2019s disease mouse models. Cell Rep 2(6):1492\u20131497","DOI":"10.1016\/j.celrep.2012.11.001"},{"key":"7802_CR78","doi-asserted-by":"crossref","unstructured":"Quinti L, Casale M, Moniot S, Pais TF, Van Kanegan MJ, Kaltenbach LS, ... Kazantsev AG (2016) SIRT2-and NRF2-targeting thiazole-containing compound with therapeutic activity in Huntington's disease models.\u00a0Cell Chem Biol 23(7):849\u2013861","DOI":"10.1016\/j.chembiol.2016.05.015"},{"key":"7802_CR79","doi-asserted-by":"crossref","unstructured":"Zoungrana LI, Krause-Hauch M, Wang H, Fatmi MK, Bates L, Li Z, ... Li J (2022) The interaction of mTOR and Nrf2 in neurogenesis and its implication in neurodegenerative diseases. Cells 11(13):2048","DOI":"10.3390\/cells11132048"},{"key":"7802_CR80","doi-asserted-by":"crossref","unstructured":"Gonchar OO, Maznychenko AV, Klyuchko OM, Mankovska IM, Butowska K, Borowik A, ... Sokolowska I (2021) C60 fullerene reduces 3-nitropropionic acid-induced oxidative stress disorders and mitochondrial dysfunction in rats by modulation of p53, Bcl-2 and Nrf2 targeted proteins. Int J Mol Sci 22(11):5444","DOI":"10.3390\/ijms22115444"},{"key":"7802_CR81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2199-9-1","volume":"9","author":"WM van Roon-Mom","year":"2008","unstructured":"van Roon-Mom WM, Pepers BA, \u2019t Hoen PA, Verwijmeren CA, den Dunnen JT, Dorsman JC, van Ommen GB (2008) Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington\u2019s disease. BMC Mol Biol 9:1\u201313","journal-title":"BMC Mol Biol"},{"key":"7802_CR82","doi-asserted-by":"crossref","unstructured":"Yang L, Calingasan NY, Thomas B, Chaturvedi RK, Kiaei M, Wille EJ, ... Beal MF (2009) Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription. PloS One 4(6):e5757","DOI":"10.1371\/journal.pone.0005757"},{"key":"7802_CR83","doi-asserted-by":"crossref","unstructured":"Stack C, Ho D, Wille E, Calingasan NY, Williams C, Liby K, ... Beal MF (2010) Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease. Free Radical Biol Med 49(2):147\u2013158","DOI":"10.1016\/j.freeradbiomed.2010.03.017"},{"key":"7802_CR84","doi-asserted-by":"crossref","unstructured":"Andreassen OA, Dedeoglu A, Ferrante RJ, Jenkins BG, Ferrante KL, Thomas M, ... Beal MF (2001) Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease.\u00a0Neurobiol Dis 8(3):479\u2013491","DOI":"10.1006\/nbdi.2001.0406"},{"key":"7802_CR85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12864-017-3745-z","volume":"18","author":"M van Hagen","year":"2017","unstructured":"van Hagen M, Piebes DG, de Leeuw WC, Vuist IM, van Roon-Mom WM, Moerland PD, Verschure PJ (2017) The dynamics of early-state transcriptional changes and aggregate formation in a Huntington\u2019s disease cell model. BMC Genomics 18:1\u201314","journal-title":"BMC Genomics"},{"issue":"2","key":"7802_CR86","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/JHD-180312","volume":"8","author":"N Arbez","year":"2019","unstructured":"Arbez N, Roby E, Akimov S, Eddings C, Ren M, Wang X, Ross CA (2019) Cysteamine protects neurons from mutant huntingtin toxicity. J Huntington\u2019s Dis 8(2):129\u2013143","journal-title":"J Huntington's Dis"},{"key":"7802_CR87","doi-asserted-by":"crossref","unstructured":"Gao Y, Chu SF, Li JP, Zhang Z, Yan JQ, Wen ZL, ... Chen NH (2015) Protopanaxtriol protects against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington's disease. Acta Pharmacol Sin 36(3):311\u2013322","DOI":"10.1038\/aps.2014.107"},{"issue":"3","key":"7802_CR88","doi-asserted-by":"publisher","first-page":"e57932","DOI":"10.1371\/journal.pone.0057932","volume":"8","author":"YN Jin","year":"2013","unstructured":"Jin YN, Yu YV, Gundemir S, Jo C, Cui M, Tieu K, Johnson GV (2013) Impaired mitochondrial dynamics and Nrf2 signaling contribute to compromised responses to oxidative stress in striatal cells expressing full-length mutant huntingtin. PLoS ONE 8(3):e57932","journal-title":"PLoS ONE"},{"issue":"11","key":"7802_CR89","doi-asserted-by":"publisher","first-page":"5620","DOI":"10.1021\/acsomega.9b02375","volume":"5","author":"S Jain","year":"2020","unstructured":"Jain S, Panuganti V, Jha S, Roy I (2020) Harmine acts as an indirect inhibitor of intracellular protein aggregation. ACS Omega 5(11):5620\u20135628","journal-title":"ACS Omega"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07802-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-024-07802-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-024-07802-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T09:16:53Z","timestamp":1737969413000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-024-07802-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,11]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["7802"],"URL":"https:\/\/doi.org\/10.1007\/s10072-024-07802-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,11]]},"assertion":[{"value":"30 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and Informed consent"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"There are no conflicts of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}